AMRUTANJANNSEAmrutanjan Health Care Limited· PharmaceuticalsHighNegative
Announced Wed, 18 Mar · 14:21 IST

Amrutanjan Health Care Limited has informed the Exchange about Action(s) initiated or orders passed

Regulatory & Legal View source PDF

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹517.25
prior close
₹520.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.2-0.1+0.2-0.5+0.3+1.2+2.5+0.4-5.0+0.7+5.4+7.9+6.1
Up moveDown movePending
AI summary

Amrutanjan Health Care has received an order dated March 17, 2026, from the Additional Commissioner of Central Excise & Customs (Appeals-II) under Sections 73 & 74 of the CGST Act, 2017. The order reverses Input Tax Credit claimed by the company for FY 2020-21 and 2021-22 due to a GSTR2A mismatch, with a tax demand of Rs. 24.29 lakh plus applicable interest and penalty. The company states it fulfilled all conditions under GST law and will file an appeal against the order. Management has indicated that the order does not have any major financial implications on the company.

Likely market impact

The financial impact is minimal, with the disputed tax demand being only Rs. 24.29 lakh — a small amount for the company. The order is being contested through appeal, so shareholders are unlikely to see any material effect on the stock or operations.